Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs ketamine sedation and core body temperature in children undergoing MRI
IRCT20250722066589N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine and ketamine (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Change in core body temperature during MRI sedation. Started Aug 2025; status: completed.
02
Drugs
dexmedetomidineketamine
Beyond the preview
Go deeper on IRCT20250722066589N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250722066589N1.